Summary of projects carried out by David Glass, D. Glass Associates, Inc., to assist U.S. and international industrial biotechnology companies prepare for and comply with government regulation of their activities.
Application and Regulation of the Use of Photosynthetic Microorganisms in Bio...David Glass
David Glass Presentation at Alternative Fuels & Chemicals Coalition Biobased Economy Conference, November 15, 2021. Discusses the potential for uses of modified algae and cyanobacteria for production of chemicals and fuels, and how such uses would be regulated in the US and elsewhere in the world.
David Glass Regulatory Presentation and Case Study BIO Pac Rim Conference Dec...David Glass
Presentation from BIO Pacific Rim Conference December 2013, providing an overview of regulations affecting industrial biotechnology, and presenting a case study of an MCAN successfully submitted to the EPA for a genetically modified cyanobacterium for production of ethanol.
David Glass BIO World Congress Algae Regulation July 2015David Glass
Presentation summarizing how industrial biotechnology projects involving genetically modified algae would be regulated in the U.S. and internationally, including strategies and road maps to obtain approvals for such projects.
David Glass Plenary Presentation at 4th Algal Biomass, Biofuels and Bioproduc...David Glass
The document discusses the history and current state of U.S. biotechnology regulation as it pertains to genetically modified algae. It notes that while the regulatory framework subjects genetically engineered organisms to additional scrutiny, approvals for commercial uses of GM algae are possible with proper planning and scientific evidence. It outlines the roles of the EPA, USDA and FDA in regulating GM organisms and provides details on relevant regulations. It also discusses scientific issues to address in risk assessments and the need for research to inform the regulatory process.
This document provides an overview of U.S. regulations for novel food ingredients, including food additives, GRAS substances, dietary supplements, and case studies on specific emerging technologies like genetically modified plants, cell-based and plant-based meats, and animal food ingredients. It describes the regulatory authorities of the FDA and USDA and various approval pathways including food additive petitions, GRAS notifications, and AAFCO new ingredient definitions.
Presentation at 2016 Fuel Ethanol Workshop, describing U.S. regulatory pathways for approval of use of modified microorganisms in animal feed, and a proposal for making such pathways simpler and more efficient for modified strains of common microorganisms.
David Glass Presentation at 2016 BIO World CongressDavid Glass
Presentation describing the status of the ongoing efforts to update and modernize the Federal Government's Coordinated Framework for Biotechnology Regulation.
David Glass World Biofuels Markets Conference Presentation, March 2011David Glass
Presentation by David Glass at 2011 World Biofuels Markets Conference, Rotterdam, the Netherlands, March 22, 2011. This presentation describes approaches being taken to use advanced biotechnology to improve the plant species being used as biofuel feedstocks. This was part of the "Energy Crops" sessions at the conference, which Dr. Glass moderated.
Application and Regulation of the Use of Photosynthetic Microorganisms in Bio...David Glass
David Glass Presentation at Alternative Fuels & Chemicals Coalition Biobased Economy Conference, November 15, 2021. Discusses the potential for uses of modified algae and cyanobacteria for production of chemicals and fuels, and how such uses would be regulated in the US and elsewhere in the world.
David Glass Regulatory Presentation and Case Study BIO Pac Rim Conference Dec...David Glass
Presentation from BIO Pacific Rim Conference December 2013, providing an overview of regulations affecting industrial biotechnology, and presenting a case study of an MCAN successfully submitted to the EPA for a genetically modified cyanobacterium for production of ethanol.
David Glass BIO World Congress Algae Regulation July 2015David Glass
Presentation summarizing how industrial biotechnology projects involving genetically modified algae would be regulated in the U.S. and internationally, including strategies and road maps to obtain approvals for such projects.
David Glass Plenary Presentation at 4th Algal Biomass, Biofuels and Bioproduc...David Glass
The document discusses the history and current state of U.S. biotechnology regulation as it pertains to genetically modified algae. It notes that while the regulatory framework subjects genetically engineered organisms to additional scrutiny, approvals for commercial uses of GM algae are possible with proper planning and scientific evidence. It outlines the roles of the EPA, USDA and FDA in regulating GM organisms and provides details on relevant regulations. It also discusses scientific issues to address in risk assessments and the need for research to inform the regulatory process.
This document provides an overview of U.S. regulations for novel food ingredients, including food additives, GRAS substances, dietary supplements, and case studies on specific emerging technologies like genetically modified plants, cell-based and plant-based meats, and animal food ingredients. It describes the regulatory authorities of the FDA and USDA and various approval pathways including food additive petitions, GRAS notifications, and AAFCO new ingredient definitions.
Presentation at 2016 Fuel Ethanol Workshop, describing U.S. regulatory pathways for approval of use of modified microorganisms in animal feed, and a proposal for making such pathways simpler and more efficient for modified strains of common microorganisms.
David Glass Presentation at 2016 BIO World CongressDavid Glass
Presentation describing the status of the ongoing efforts to update and modernize the Federal Government's Coordinated Framework for Biotechnology Regulation.
David Glass World Biofuels Markets Conference Presentation, March 2011David Glass
Presentation by David Glass at 2011 World Biofuels Markets Conference, Rotterdam, the Netherlands, March 22, 2011. This presentation describes approaches being taken to use advanced biotechnology to improve the plant species being used as biofuel feedstocks. This was part of the "Energy Crops" sessions at the conference, which Dr. Glass moderated.
David Glass Presentation at 2010 Algae Biomass SummitDavid Glass
Slides from a presentation given by David Glass, "Impact of Biotechnology Regulations on Use of Genetically Modified Algae in Biofuel Production", at the 2010 Algae Biomass Summit, Phoenix, AZ, September 28, 2010.
Challenges and Opportunities in Industrial Biotech RegulationDavid Glass
Presentation at Society for Biological Engineering Workshop, "Technology Challenges and Opportunities in Commercializing Industrial Biotechnology", San Diego September 29, 2015.
This is a presentation I made on February 2, 2010 at the EUEC 2010 conference in Phoenix. The talk included an overview of the approaches being pursued to use biotechnology to improve microorganisms, algae and plants for biofuel production and the companies pursuing these strategies, and discussion of the impact of biotech regulations on these projects and the prospects for use of engineered organisms in commercial biofuel production. You can find more detailed information on the topics discussed in this talk on my blog at http://dglassassociates.wordpress.com.
Regulatory aspects associated to genome editing in IndiaOECD Environment
This document summarizes India's existing biosafety regulatory framework for genetically modified organisms (GMOs) and gene technologies. It provides an overview of the key agencies and committees that regulate GMOs in India according to the Rules for Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/GMOs. It also outlines the process for approving GM crops in India and notes that new gene technologies will be regulated under the existing framework while appropriate guidelines are developed. Currently, GM cotton, brinjal, and mustard have been commercialized or are awaiting approval in India.
04 control of spills and mechanism of implementation of biosafety guidelinesIndranil Bhattacharjee
1. The document outlines procedures for controlling spills of biological materials in laboratories, including spills in biological safety cabinets, open laboratories, centrifuges, and on persons. It describes wearing protective equipment, warning others, and using appropriate disinfectants.
2. It then describes the mechanism for implementing biosafety guidelines in India, including committees that provide oversight of recombinant DNA research. The key committees are the Recombinant DNA Advisory Committee, Institutional Biosafety Committees, and the Review Committee on Genetic Manipulation.
3. The committees provide guidance on biosafety, review research proposals, oversee safety training, and ensure containment facilities and procedures are followed to regulate genetic engineering activities and protect
1) The document discusses biological control agents that are permitted for use in organic farming to control various pests including aphids, caterpillars, leaf miners, mealybugs, scale insects, sciarid flies, slugs, spider mites, thrips, and more.
2) The control agents are living organisms like parasitic wasps, predatory mites, ladybird beetles, nematodes, and others that attack the pest species.
3) The document provides the name of each product, the pest it controls, approved crops, and additional information to help farmers select the right control agent.
The document discusses various US and European regulatory agencies that oversee different aspects of biotechnology. The FDA regulates food additives and drugs. The EPA regulates genetically modified crops and water quality. The EPA, FDA and USDA regulate environmental releases of genetically engineered organisms. Patents regulate drugs by requiring them to be functional with no malfunctions. New streamlined drug approval processes in Europe have reduced approval times from four years to one. Europe has the most applicants for cancer therapy patents because purification steps are often individually patented. Firms should evaluate all aspects of production after the Fluvirin incident highlighted regulatory issues. ESTs cannot be patented because they only identify genetic locations rather than having a specific utility. Drug approvals take less time in
This PowerPoint presentation outlines the regulatory requirements and process for registering biopesticides in India. It discusses the Insecticides Act of 1968, which regulates the import, manufacture, and sale of insecticides. The Central Insecticides Board and Registration Committee evaluate applications and register pesticides. Thirty-eight microbial biopesticides across bacteria, fungi, and viruses have been included in the Act's schedule. Requirements for registration include submitting data on the product's chemistry, bioefficacy, toxicity, packaging, and labeling. Currently, the market for biopesticides in India is small but growing rapidly, though supply still cannot meet demand.
The document outlines standards for Stockfree-Organic certification. Key points include:
- Animal products are prohibited as inputs on registered holdings to attain the Stockfree-Organic symbol. This includes animal manures and keeping animals for food.
- Primary sources of soil fertility must be plant-based and come from materials on the registered holding or other certified organic systems. Most synthetic fertilizers and inputs of animal origin are prohibited or restricted.
- Propagation materials must be organically grown and GMOs are prohibited. Seeds from outside the holding are restricted and non-organic seeds will eventually be prohibited.
- Crop rotations and soil management techniques are required to replenish organic matter and minimize environmental pollution.
Position Summary:
Responsible for developing, implementing and managing systems to mitigate the risk of experiencing unacceptable levels of bioburden in products. This includes establishing best practices, process controls and environmental monitoring programs that reduce the potential for microbial product contamination. Also responsible for training manufacturing associates on aseptic technique and monitoring and coaching production associates at their work stations.
Key Responsibilities:
•Microbial sampling, identification & bioburden mapping of production facilities.
•Bioburden challenge studies for existing and new product formulations.
•Bioburden risk assessment and validation for new product development process.
•Aseptic process development and process control.
•Environmental and water monitoring of Rockford and Wisconsin sites.
•Interpret test results and initiate corrective actions as needed.
•Assist with equipment and process cleaning validations.
•Clean room management inclusive of mentoring and supervising 23 clean room associates.
•Microbial test-method development as per USP test method suitability.
•Contamination investigations & implementation of corrective actions.
•Prepare reports and present data with conclusions.
•Maintain microbiology laboratory equipment and supplies.
Also efficiently performed Preservative Efficacy Challenge Tests, Environmental monitoring, LAL Endotoxin testing (Kinetic & Gel Clot methods), Microbial Ingress Integrity Testing (both Dye Penetration & Bacterial Challenge testing), Microbial Identification using Biolog, Mycoplasma testing of products using Luminometer, Bioburden & Water testing.
Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014" Dr. Ravi Dhar
An overview of Intellectual Property Barriers in Generic Vaccines & how to circumvent these. Issues of affordability in tough Patent regime has also been mentioned.
This document discusses the effects of irradiation on food, including how it works to reduce microorganisms and extend shelf-life while maintaining quality. It outlines different irradiation doses and their purposes, such as inhibiting sprouting or reducing pathogens. Several foods currently treated are mentioned, as well as international standards for irradiation as a phytosanitary measure. The document also addresses factors like nutritional value, quality impacts, and regulations regarding labeled of irradiated foods.
On September 17, the Organic Council of Ontario hosted a webinar on proposed changes to the Canadian Organic Standards. Public comments will be accepted by the Canadian General Standards Board until September 30, 2019.
Panelists included: Hugh Martin, Rob Wallbridge, Joel Aitken, Norm Hansen, Rochelle Eisen, Simon Jacques, Nicole Boudreau
In this webinar, you will learn:
Sources of endotoxin contamination
Contamination control strategy
Endotoxin removal strategies
Detailed description:
Endotoxin, a lipopolysaccharide (LPS), is a type of pyrogen and is a component of the exterior cell wall of Gram-negative bacteria. To ensure safety on patient’s endotoxin content in the drug should always be controlled. In a biological processing it may emanate from facility, utility, raw materials, process, and personnel. In this webinar we discuss the regulatory norms, strategies for prevention & removal of endotoxin to ensure that the final drug product is safe.
This document discusses the applications of nanotechnology in the food industry. It begins with an introduction and discusses the need for nanotechnology in the food sector. It then covers various applications of nanotechnology including nanoencapsulation, nanoemulsions, nanoparticles for active packaging, nanoclays for packaging, and nanosensors for packaging and processing plants. Specific examples of products that utilize these nanotechnology applications are also provided. The document concludes by noting regulatory considerations for nanotechnology in food.
Biotechnology is being applied across multiple industries in North Carolina, including animal agriculture, aquaculture, defense, energy, environment, forensics, and forestry. Some key applications include improved animal health and breeding, disease resistance in aquaculture, developing defenses against biological weapons, producing sustainable biofuels, environmental remediation, DNA testing for forensics, and increasing forest growth and pest/disease resistance. Biotechnology is providing new tools that are enhancing North Carolina's industries and economy.
The document discusses testing procedures for various parameters of food and neutraceutical products. It describes methods for testing microbial load, bioburden, aerobic count, yeast/mold count, and antimicrobial assays. It also discusses testing nutritional value through laboratory analysis of proteins, fibers, vitamins, minerals and more. Other tests covered include heavy metals, calorific value, and label claim verification. The document also provides information on certification standards like Agmark, BIS, and FSSAI.
Fernando Garcia has over 15 years of experience in the regulatory and product stewardship field, specializing in fast-tracking new product approvals. He has worked at Amyris as their Senior Director of Regulatory Affairs, leading a team that obtained global regulatory registrations and approvals for renewable fuels, chemicals, and other products. Prior to that, he spent 13 years at Bombardier managing their regulatory compliance programs across North America, Latin America, Europe, and Asia. He has extensive experience interfacing with regulatory agencies around the world including EPA, FDA, and others.
David Glass Algae Biomass Final 10.03.22.pdfDavid Glass
The document discusses strategies for obtaining regulatory approval to use algae and cyanobacteria for chemical and fuel production. It provides an overview of the potential industrial uses of photosynthetic microorganisms, as well as strategies companies are taking to genetically modify algae and cyanobacteria for increased productivity. The document then focuses on US EPA regulation of industrial biotechnology under the Toxic Substances Control Act, and what activities require EPA approval. It also discusses regulatory risk assessment and provides examples of regulatory approvals that companies have received for field testing and commercial use of modified algae and cyanobacteria.
David Glass Presentation at 2010 Algae Biomass SummitDavid Glass
Slides from a presentation given by David Glass, "Impact of Biotechnology Regulations on Use of Genetically Modified Algae in Biofuel Production", at the 2010 Algae Biomass Summit, Phoenix, AZ, September 28, 2010.
Challenges and Opportunities in Industrial Biotech RegulationDavid Glass
Presentation at Society for Biological Engineering Workshop, "Technology Challenges and Opportunities in Commercializing Industrial Biotechnology", San Diego September 29, 2015.
This is a presentation I made on February 2, 2010 at the EUEC 2010 conference in Phoenix. The talk included an overview of the approaches being pursued to use biotechnology to improve microorganisms, algae and plants for biofuel production and the companies pursuing these strategies, and discussion of the impact of biotech regulations on these projects and the prospects for use of engineered organisms in commercial biofuel production. You can find more detailed information on the topics discussed in this talk on my blog at http://dglassassociates.wordpress.com.
Regulatory aspects associated to genome editing in IndiaOECD Environment
This document summarizes India's existing biosafety regulatory framework for genetically modified organisms (GMOs) and gene technologies. It provides an overview of the key agencies and committees that regulate GMOs in India according to the Rules for Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/GMOs. It also outlines the process for approving GM crops in India and notes that new gene technologies will be regulated under the existing framework while appropriate guidelines are developed. Currently, GM cotton, brinjal, and mustard have been commercialized or are awaiting approval in India.
04 control of spills and mechanism of implementation of biosafety guidelinesIndranil Bhattacharjee
1. The document outlines procedures for controlling spills of biological materials in laboratories, including spills in biological safety cabinets, open laboratories, centrifuges, and on persons. It describes wearing protective equipment, warning others, and using appropriate disinfectants.
2. It then describes the mechanism for implementing biosafety guidelines in India, including committees that provide oversight of recombinant DNA research. The key committees are the Recombinant DNA Advisory Committee, Institutional Biosafety Committees, and the Review Committee on Genetic Manipulation.
3. The committees provide guidance on biosafety, review research proposals, oversee safety training, and ensure containment facilities and procedures are followed to regulate genetic engineering activities and protect
1) The document discusses biological control agents that are permitted for use in organic farming to control various pests including aphids, caterpillars, leaf miners, mealybugs, scale insects, sciarid flies, slugs, spider mites, thrips, and more.
2) The control agents are living organisms like parasitic wasps, predatory mites, ladybird beetles, nematodes, and others that attack the pest species.
3) The document provides the name of each product, the pest it controls, approved crops, and additional information to help farmers select the right control agent.
The document discusses various US and European regulatory agencies that oversee different aspects of biotechnology. The FDA regulates food additives and drugs. The EPA regulates genetically modified crops and water quality. The EPA, FDA and USDA regulate environmental releases of genetically engineered organisms. Patents regulate drugs by requiring them to be functional with no malfunctions. New streamlined drug approval processes in Europe have reduced approval times from four years to one. Europe has the most applicants for cancer therapy patents because purification steps are often individually patented. Firms should evaluate all aspects of production after the Fluvirin incident highlighted regulatory issues. ESTs cannot be patented because they only identify genetic locations rather than having a specific utility. Drug approvals take less time in
This PowerPoint presentation outlines the regulatory requirements and process for registering biopesticides in India. It discusses the Insecticides Act of 1968, which regulates the import, manufacture, and sale of insecticides. The Central Insecticides Board and Registration Committee evaluate applications and register pesticides. Thirty-eight microbial biopesticides across bacteria, fungi, and viruses have been included in the Act's schedule. Requirements for registration include submitting data on the product's chemistry, bioefficacy, toxicity, packaging, and labeling. Currently, the market for biopesticides in India is small but growing rapidly, though supply still cannot meet demand.
The document outlines standards for Stockfree-Organic certification. Key points include:
- Animal products are prohibited as inputs on registered holdings to attain the Stockfree-Organic symbol. This includes animal manures and keeping animals for food.
- Primary sources of soil fertility must be plant-based and come from materials on the registered holding or other certified organic systems. Most synthetic fertilizers and inputs of animal origin are prohibited or restricted.
- Propagation materials must be organically grown and GMOs are prohibited. Seeds from outside the holding are restricted and non-organic seeds will eventually be prohibited.
- Crop rotations and soil management techniques are required to replenish organic matter and minimize environmental pollution.
Position Summary:
Responsible for developing, implementing and managing systems to mitigate the risk of experiencing unacceptable levels of bioburden in products. This includes establishing best practices, process controls and environmental monitoring programs that reduce the potential for microbial product contamination. Also responsible for training manufacturing associates on aseptic technique and monitoring and coaching production associates at their work stations.
Key Responsibilities:
•Microbial sampling, identification & bioburden mapping of production facilities.
•Bioburden challenge studies for existing and new product formulations.
•Bioburden risk assessment and validation for new product development process.
•Aseptic process development and process control.
•Environmental and water monitoring of Rockford and Wisconsin sites.
•Interpret test results and initiate corrective actions as needed.
•Assist with equipment and process cleaning validations.
•Clean room management inclusive of mentoring and supervising 23 clean room associates.
•Microbial test-method development as per USP test method suitability.
•Contamination investigations & implementation of corrective actions.
•Prepare reports and present data with conclusions.
•Maintain microbiology laboratory equipment and supplies.
Also efficiently performed Preservative Efficacy Challenge Tests, Environmental monitoring, LAL Endotoxin testing (Kinetic & Gel Clot methods), Microbial Ingress Integrity Testing (both Dye Penetration & Bacterial Challenge testing), Microbial Identification using Biolog, Mycoplasma testing of products using Luminometer, Bioburden & Water testing.
Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014" Dr. Ravi Dhar
An overview of Intellectual Property Barriers in Generic Vaccines & how to circumvent these. Issues of affordability in tough Patent regime has also been mentioned.
This document discusses the effects of irradiation on food, including how it works to reduce microorganisms and extend shelf-life while maintaining quality. It outlines different irradiation doses and their purposes, such as inhibiting sprouting or reducing pathogens. Several foods currently treated are mentioned, as well as international standards for irradiation as a phytosanitary measure. The document also addresses factors like nutritional value, quality impacts, and regulations regarding labeled of irradiated foods.
On September 17, the Organic Council of Ontario hosted a webinar on proposed changes to the Canadian Organic Standards. Public comments will be accepted by the Canadian General Standards Board until September 30, 2019.
Panelists included: Hugh Martin, Rob Wallbridge, Joel Aitken, Norm Hansen, Rochelle Eisen, Simon Jacques, Nicole Boudreau
In this webinar, you will learn:
Sources of endotoxin contamination
Contamination control strategy
Endotoxin removal strategies
Detailed description:
Endotoxin, a lipopolysaccharide (LPS), is a type of pyrogen and is a component of the exterior cell wall of Gram-negative bacteria. To ensure safety on patient’s endotoxin content in the drug should always be controlled. In a biological processing it may emanate from facility, utility, raw materials, process, and personnel. In this webinar we discuss the regulatory norms, strategies for prevention & removal of endotoxin to ensure that the final drug product is safe.
This document discusses the applications of nanotechnology in the food industry. It begins with an introduction and discusses the need for nanotechnology in the food sector. It then covers various applications of nanotechnology including nanoencapsulation, nanoemulsions, nanoparticles for active packaging, nanoclays for packaging, and nanosensors for packaging and processing plants. Specific examples of products that utilize these nanotechnology applications are also provided. The document concludes by noting regulatory considerations for nanotechnology in food.
Biotechnology is being applied across multiple industries in North Carolina, including animal agriculture, aquaculture, defense, energy, environment, forensics, and forestry. Some key applications include improved animal health and breeding, disease resistance in aquaculture, developing defenses against biological weapons, producing sustainable biofuels, environmental remediation, DNA testing for forensics, and increasing forest growth and pest/disease resistance. Biotechnology is providing new tools that are enhancing North Carolina's industries and economy.
The document discusses testing procedures for various parameters of food and neutraceutical products. It describes methods for testing microbial load, bioburden, aerobic count, yeast/mold count, and antimicrobial assays. It also discusses testing nutritional value through laboratory analysis of proteins, fibers, vitamins, minerals and more. Other tests covered include heavy metals, calorific value, and label claim verification. The document also provides information on certification standards like Agmark, BIS, and FSSAI.
Fernando Garcia has over 15 years of experience in the regulatory and product stewardship field, specializing in fast-tracking new product approvals. He has worked at Amyris as their Senior Director of Regulatory Affairs, leading a team that obtained global regulatory registrations and approvals for renewable fuels, chemicals, and other products. Prior to that, he spent 13 years at Bombardier managing their regulatory compliance programs across North America, Latin America, Europe, and Asia. He has extensive experience interfacing with regulatory agencies around the world including EPA, FDA, and others.
David Glass Algae Biomass Final 10.03.22.pdfDavid Glass
The document discusses strategies for obtaining regulatory approval to use algae and cyanobacteria for chemical and fuel production. It provides an overview of the potential industrial uses of photosynthetic microorganisms, as well as strategies companies are taking to genetically modify algae and cyanobacteria for increased productivity. The document then focuses on US EPA regulation of industrial biotechnology under the Toxic Substances Control Act, and what activities require EPA approval. It also discusses regulatory risk assessment and provides examples of regulatory approvals that companies have received for field testing and commercial use of modified algae and cyanobacteria.
This document summarizes a student design project for a sustainable pharmaceutical production facility. Key points include:
- The facility would produce several controlled active pharmaceutical ingredients more sustainably through innovations like reducing solvent and water use, utilizing green energy and a local poppy crop, and continuous processing.
- Analyses found the sustainable approaches improved long-term profits despite higher initial costs by cutting operating costs and emissions over the plant's lifespan.
- The project concluded that pharmaceutical companies pursuing sustainability through modern facilities and innovative technology can become more profitable than those relying solely on traditional methods.
Parveen Bhatarah has over 15 years of experience in pharmaceutical management, API development, drug substance manufacturing, technology transfer, and formulation development. They have successfully developed, scaled up, and manufactured a wide range of drug substances and formulations, and have transferred technologies for commercial manufacturing. Parveen also has experience evaluating and qualifying CMOs, building industry partnerships, and presenting scientific findings to regulatory agencies.
U.S. and International Regulation of Microbial Inoculants and Soil AdditivesDavid Glass
Presentation at the International Phytobiomes Conference, September 2012, Denver, Colorado. The talk describes US and international regulation that might affect the testing and development of modified microorganisms for nonpesticidal uses in agriculture, such as biofertilizers or certain biostimulants.
Antone Mello has over 25 years of experience in polymer chemistry, manufacturing, and environmental health and safety. He has expertise in product development, regulatory compliance, manufacturing, and troubleshooting. As a sole proprietor, he has performed safety training and procedures to help companies obtain ISO9001 certification. He has also developed novel coatings, chemicals, and additives. Previously, he worked as a chemist and helped develop new products, scale up manufacturing, and ensure quality and regulatory compliance for a chemical company. He has a background in analytical chemistry and helped with environmental testing and regulatory projects.
Green Approaches For The Industrial Production Of Active Pharmaceutical Ingre...IRJET Journal
This document discusses green approaches for the industrial production of active pharmaceutical ingredients (APIs). It begins by introducing the environmental issues associated with traditional chemical production routes for APIs. It then discusses various methods for converting biomass into APIs through more sustainable means such as fermentation and biocatalysis. The goal is to develop environmentally friendly industrial processes that minimize waste and pollution while efficiently producing APIs.
The document provides a summary of Robert Llantero Loquillano's background and qualifications as a microbiologist and plant pathologist. It includes details of his educational background in applied biology and phytopathology. It also outlines his work experience in quality control and microbiology roles for various companies in Saudi Arabia, the UAE, and the Philippines. It highlights his skills in implementing standards like HACCP, cGMP, ISO, and developing quality manuals.
Genetic Modified Organism Regulation in IndiaMeehirMerai
The document discusses India's standards for the release and use of genetically modified organisms (GMOs). It provides definitions of GMOs and explains how they are created by inserting foreign genes into organisms' DNA. It then discusses the main benefits of genetically modifying agricultural plants and animals. The document goes on to summarize India's policies and regulatory framework for ensuring biosafety of GMOs, including guidelines, committees, and containment facilities required for research. It also notes the countries that use GMO technology the most and some concerns about their use.
Natural Products: The Case for a Product Development Paradigm in Malaysian Na...Murray Hunter
The document discusses the need for a new paradigm in natural product research in Malaysia that focuses on development and commercialization, rather than just discovery and publication. It outlines a natural product development process involving biological and regulatory screening, market development, technical development, and commercialization strategies. This requires a shift from single discipline research to multidisciplinary collaboration with an emphasis on potential applications and economic viability.
Kemxtree is a contract research organization that offers chemistry services to the pharmaceutical industry. It has state-of-the-art facilities and equipment in India and experienced staff. Kemxtree provides services such as custom synthesis, process development, and analytical development. It ensures client confidentiality and intellectual property protection. Kemxtree is looking to partner with companies to provide cost-effective chemistry solutions.
T. Dhanasekaran has over 25 years of experience in research and development, quality control, and technical marketing in the chemical and pharmaceutical industries. He has expertise in developing fine chemicals, specialty chemicals, and pharmaceutical intermediates from the lab scale to the pilot plant scale. Some of his achievements include developing over 50 pharmaceutical intermediates and improving the quality and yields of various products. He is skilled in multiple analytical techniques and process development.
The document provides an overview of the DOE/EE/OBP Biomass Program. The mission is to develop technologies to transform biomass into biofuels, biopower and high-value products. Goals include demonstrating an integrated biomass to fuels process by 2005 and helping establish the first large-scale biorefinery by 2010. The strategy involves removing technical barriers in thermo-chemical and sugar platforms. Major funding comes from congressional earmarks, which have grown significantly but reduced available funds for planned R&D.
Presentation given by Cipan at the BioEngineering Week (Semana da Bioengenharia – SBE) an initiative of the Bioengineering Department students of the Masters in Biological Engineering, Biomedical Engineering, Biotechnology and Microbiology of the Instituto Superior Técnico – Lisboa (http://sbe.tecnico.ulisboa.pt/).
George Snow has over 20 years of experience in research and development of dispersion polymers. He has worked at Lubrizol Corporation since 1988, holding several senior roles where he developed new products, conducted manufacturing troubleshooting, provided technical support to customers, and led projects with budgets up to $2 million. Snow has filed several patent applications, received patents, and published papers in his field. He has a Bachelor's degree in Chemistry and additional training in polymer science and business skills.
1. SoilLife aims to discover and develop new antibiotic drugs from soil samples to treat multi-drug resistant bacterial infections like MRSA.
2. Their key product "Anneclymycin" shows strong activity against Acinetobacter baumannii and was originally extracted from Brazilian soil samples.
3. Over 5 years, they plan to launch Anneclymycin, start 5 clinical trials, and acquire 20% of the multi-drug resistant Acinetobacter baumannii treatment market.
Process guidelines for foreign companies exporting infant formula to ChinaGlobal Foodmate
As a leading China food regulation consulting company, FoodMate developed this report to outline challenges for foreign companies exporting product to China. An in depth regulation mapping and step by step compliance guideline of exporting infant formula to China is also interpreted in this report.
Tony Burfield at World Perfumery Congress Cannes June 2010Tony Burfield
The document discusses how increasing regulation of fragrance ingredients through the EU Cosmetics Directive and IFRA standards has negatively impacted the art of perfumery. Stricter limits on ingredients due to safety classifications have reduced creativity and availability of natural materials. This has particularly burdened small businesses who cannot afford to participate in setting regulatory policy. The role and autonomy of perfumers has also declined as they must work within tighter restrictions.
Similar to David Glass Industrial Biotechnology Regulatory Experience (20)
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Tastemy Pandit
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...my Pandit
Dive into the steadfast world of the Taurus Zodiac Sign. Discover the grounded, stable, and logical nature of Taurus individuals, and explore their key personality traits, important dates, and horoscope insights. Learn how the determination and patience of the Taurus sign make them the rock-steady achievers and anchors of the zodiac.
𝐔𝐧𝐯𝐞𝐢𝐥 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐄𝐧𝐞𝐫𝐠𝐲 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐰𝐢𝐭𝐡 𝐍𝐄𝐖𝐍𝐓𝐈𝐃𝐄’𝐬 𝐋𝐚𝐭𝐞𝐬𝐭 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬
Explore the details in our newly released product manual, which showcases NEWNTIDE's advanced heat pump technologies. Delve into our energy-efficient and eco-friendly solutions tailored for diverse global markets.
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...APCO
The Radar reflects input from APCO’s teams located around the world. It distils a host of interconnected events and trends into insights to inform operational and strategic decisions. Issues covered in this edition include:
Industrial Tech SW: Category Renewal and CreationChristian Dahlen
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
How MJ Global Leads the Packaging Industry.pdfMJ Global
MJ Global's success in staying ahead of the curve in the packaging industry is a testament to its dedication to innovation, sustainability, and customer-centricity. By embracing technological advancements, leading in eco-friendly solutions, collaborating with industry leaders, and adapting to evolving consumer preferences, MJ Global continues to set new standards in the packaging sector.
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Final ank Satta Matka Dpbos Final ank Satta Matta Matka 143 Kalyan Matka Guessing Final Matka Final ank Today Matka 420 Satta Batta Satta 143 Kalyan Chart Main Bazar Chart vip Matka Guessing Dpboss 143 Guessing Kalyan night
Easily Verify Compliance and Security with Binance KYCAny kyc Account
Use our simple KYC verification guide to make sure your Binance account is safe and compliant. Discover the fundamentals, appreciate the significance of KYC, and trade on one of the biggest cryptocurrency exchanges with confidence.
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesHolger Mueller
Holger Mueller of Constellation Research shares his key takeaways from SAP's Sapphire confernece, held in Orlando, June 3rd till 5th 2024, in the Orange Convention Center.
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
[To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
This PowerPoint compilation offers a comprehensive overview of 20 leading innovation management frameworks and methodologies, selected for their broad applicability across various industries and organizational contexts. These frameworks are valuable resources for a wide range of users, including business professionals, educators, and consultants.
Each framework is presented with visually engaging diagrams and templates, ensuring the content is both informative and appealing. While this compilation is thorough, please note that the slides are intended as supplementary resources and may not be sufficient for standalone instructional purposes.
This compilation is ideal for anyone looking to enhance their understanding of innovation management and drive meaningful change within their organization. Whether you aim to improve product development processes, enhance customer experiences, or drive digital transformation, these frameworks offer valuable insights and tools to help you achieve your goals.
INCLUDED FRAMEWORKS/MODELS:
1. Stanford’s Design Thinking
2. IDEO’s Human-Centered Design
3. Strategyzer’s Business Model Innovation
4. Lean Startup Methodology
5. Agile Innovation Framework
6. Doblin’s Ten Types of Innovation
7. McKinsey’s Three Horizons of Growth
8. Customer Journey Map
9. Christensen’s Disruptive Innovation Theory
10. Blue Ocean Strategy
11. Strategyn’s Jobs-To-Be-Done (JTBD) Framework with Job Map
12. Design Sprint Framework
13. The Double Diamond
14. Lean Six Sigma DMAIC
15. TRIZ Problem-Solving Framework
16. Edward de Bono’s Six Thinking Hats
17. Stage-Gate Model
18. Toyota’s Six Steps of Kaizen
19. Microsoft’s Digital Transformation Framework
20. Design for Six Sigma (DFSS)
To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....Lacey Max
“After being the most listed dog breed in the United States for 31
years in a row, the Labrador Retriever has dropped to second place
in the American Kennel Club's annual survey of the country's most
popular canines. The French Bulldog is the new top dog in the
United States as of 2022. The stylish puppy has ascended the
rankings in rapid time despite having health concerns and limited
color choices.”
Call8328958814 satta matka Kalyan result satta guessing➑➌➋➑➒➎➑➑➊➍
Satta Matka Kalyan Main Mumbai Fastest Results
Satta Matka ❋ Sattamatka ❋ New Mumbai Ratan Satta Matka ❋ Fast Matka ❋ Milan Market ❋ Kalyan Matka Results ❋ Satta Game ❋ Matka Game ❋ Satta Matka ❋ Kalyan Satta Matka ❋ Mumbai Main ❋ Online Matka Results ❋ Satta Matka Tips ❋ Milan Chart ❋ Satta Matka Boss❋ New Star Day ❋ Satta King ❋ Live Satta Matka Results ❋ Satta Matka Company ❋ Indian Matka ❋ Satta Matka 143❋ Kalyan Night Matka..
Call8328958814 satta matka Kalyan result satta guessing
David Glass Industrial Biotechnology Regulatory Experience
1. D. Glass Associates, Inc.
124 Bird Street Phone 617-653-9945
Needham, MA 02492 Fax 781-449-8045
www.dglassassociates.com dglass@dglassassociates.com
David J. Glass, Ph.D.
Experience with Industrial Biotechnology Regulation
EPA TSCA Biotechnology Program
Extensive experience with EPA’s biotechnology regulations under TSCA, dating back to the Agency’s
interim policy in the late 1980s. Coordinated the drafting of three submitted Microbial Commercial
Activity Notices (MCANs) with others in preparation, assisted in the preparation of one
Premanufacture Notice. Assisted companies in compliance with the Tier 1 exemption and R&D
exemption under these regulations. Facilitated agency interactions and advised companies on the
impact of the biotechnology regulations on their activities. Specific projects have included.
Bio-based chemical company. Advised company on applicability of TSCA biotechnology regulations
to the development of modified microorganisms for chemical production; currently coordinating
preparation of an MCAN for the modified strains (follow-on to a project conducted in 2010).
European developer of microbial strains for biofuel production. Advised and assisted in
compliance with the TSCA regulations, including successful filing of an MCAN for novel strains.
Industrial biotechnology company. Advised and assisted on various matters relating to compliance
with TSCA regulations, including planning for MCAN and PMN filings, coordinating meeting with EPA
staff, and assisting in compliance with Tier I exemption requirements.
Advanced ethanol company. Advised company on various matters relating to TSCA biotechnology
regulations. In 2007-11 provided advice on the impact of TSCA regulations on the development of
modified microbial strains for ethanol production; coordinated presubmission meeting with EPA staff.
European industrial biotechnology company. Advised on applicability of TSCA regulations,
coordinated in-person consultation with EPA staff.
Laboratory and research products company. Advised company on applicability of TSCA
regulations, facilitating interactions with EPA regarding status of company products under the rule.
Start-up company developing novel enzymes. Advised on the regulatory status of proposed
products, including creating a strategic plan for EPA regulatory compliance.
Developer of novel microbial strains. Confirmed the applicability of its strains for the tiered
exemptions under the EPA TSCA biotechnology regulations.
Several companies. Advised companies on questions relating to use of GMOs for fuel or chemical
production under TSCA regulations, and on other U.S. and international regulatory questions.
Regulation of New Animal Feed Ingredients
European developer of microbial strains for biofuel production. Submitted AAFCO Ingredient
Definition request for use of the company’s novel strains in animal feed, also coordinating expert
panel review of GRAS status for this product.
European industrial biotechnology company. Assisting in preparations for GRAS determination for
novel microbial animal feed ingredient, including coordination of visit to FDA. Also provided
information on regulatory status of other products in multiple industry sectors and geographies.
International bio-based chemical company. Helped determine FDA regulatory status of a
biotechnology production process for an animal feed ingredient.
2. April 2016 David Glass Regulatory Experience Page 2
European renewable fuels company. Assisted in planning for AAFCO submission and GRAS
determination for a novel processing aid in animal feed.
Several companies. Advised companies on strategies and planning to gain approvals for the use of
inactivated microbial biomass as an animal feed ingredient.
Renewable Fuel Regulations
Joule Unlimited Technologies. Obtained EPA approvals for a new fuel pathway under the
Renewable Fuel Standard and applications for EPA certification for sale of the fuel (see below).
European renewable fuels company. Helped company clarify interpretation of certain pathway
definitions under the Renewable Fuel Standard.
European industrial biotechnology company. Provided strategic background information on
renewable fuels and biotechnology regulations.
Other Regulatory Matters
Industrial biotechnology company. Provided strategic consultation for regulatory compliance for
proposed use of novel microorganisms in food, animal feed, and bio-based chemical applications,
including assessment of applicable regulations in a specific global region.
Developer of a novel biofuel feedstock. Completed a detailed market and regulatory analysis for a
company investigating the use in animal feed of a novel energy crop species.
International biotechnology company. Assisted company identify regulatory status, markets and
potential partners for products that enhance industrial enzyme activity.
Asian bioproducts company. Advised on regulatory status of enzyme products in North America.
At Joule Unlimited Technologies (in-house and as a retained consultant)
Coordinated presubmission meetings with EPA staff; worked with company scientists, engineers and
outside counsel to prepare a Microbial Commercial Activity Notice (MCAN) for a modified
cyanobacteria strain for production of ethanol; coordinated negotiation of a consent order for approval
of limited activities under the MCAN. Coordinated preparation of a new pathway petition to EPA under
the Renewable Fuel Standard, approved March 2016, achieved EPA registration for E10 and E15
ethanol, and obtained an Alcohol Fuel Production permit from the Alcohol Tax and Trade Bureau.
Earlier activities as an independent consultant
2010-2011. National Renewable Energy Laboratory. Worked with staff and outside counsel to
prepare an MCAN for a modified microbial strain for ethanol production.
2010. Cellulosic ethanol company. Presented seminar on TSCA biotechnology regulations as part
of half-day consulting visit.
2010. Cellulosic ethanol company. Advised company on applicability of TSCA biotechnology
regulations to the use of modified microbial strains for production of ethanol.
2007-2010. Projects for the bio-based chemical company and advanced ethanol company
described above.
David Glass has been involved with biotechnology regulation since the mid-1980s. For BioTechnica
International in 1988-90 he obtained some of the earliest EPA approvals for outdoor field tests of live
genetically modified agricultural microorganisms, and later advised agricultural and environmental
biotechnology companies on the impact of government regulation on their planned uses of modified
microorganisms. Information on Dr. Glass’s activities prior to 2007 can be found on the D. Glass
Associates, Inc. website.